Literature DB >> 16565915

Training patients with schizophrenia with the community re-entry module: a controlled study.

Yutao Xiang1, Yongzhen Weng, Wenyong Li, Liang Gao, Guolan Chen, Ling Xie, Yanli Chang, Wai-Kwong Tang, Gabor S Ungvari.   

Abstract

BACKGROUND: There is increasing evidence indicating that the Community Re-entry Module (CRM), a brief, structured instrument, could guide an effective intervention for patients with schizophrenia. This study evaluated the effectiveness of the Chinese version of the CRM with respect to improvement in psychiatric symptoms, social functioning as well as relapse and re-hospitalization rates in comparison with a supportive counseling (SC) intervention.
METHOD: Ninety-six outpatients with DSM-IV schizophrenia were randomly allocated to either CRM (N=48) or an equally intensive intervention of SC (N=48). The CRM was composed of 16 one-hour sessions, which were conducted with groups of 6-8 patients on a twice-a-week schedule. The two groups received routine psychiatric outpatient care during the intervention. Participants were assessed on an intention-to-treat basis with the Positive and Negative Syndrome Scales (PANSS), with the Social Disability Screening Schedule (SDSS) by two independent raters before and immediately after intervention, and at 6-month follow-up. The number of relapse and re-hospitalization were also documented.
RESULTS: The CRM group significantly improved in terms of psychiatric symptoms and social functioning compared with the SC group. Rates of relapse and re-hospitalization in the CRM group were lower although the difference between the two groups was not statistically significant.
CONCLUSIONS: The study supports the feasibility and effectiveness of the Chinese version of the CRM as an effective psychosocial intervention for Chinese patients with schizophrenia to improve psychopathology, social functioning and relapse and re-hospitalization rates.

Entities:  

Mesh:

Year:  2006        PMID: 16565915     DOI: 10.1007/s00127-006-0050-6

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  15 in total

1.  Reliability and validity of the positive and negative syndrome scale for schizophrenics.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Psychiatry Res       Date:  1988-01       Impact factor: 3.222

Review 2.  The psychosocial treatment of schizophrenia: an update.

Authors:  J Bustillo; J Lauriello; W Horan; S Keith
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

Review 3.  Psychopharmacologic treatment of schizophrenia.

Authors:  J M Kane; S R Marder
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

4.  Future opportunities and challenges for the development of psychiatric rehabilitation in China.

Authors:  M R Phillips; V Pearson
Journal:  Br J Psychiatry Suppl       Date:  1994-08

5.  Training persons with schizophrenia in illness self-management: a randomized controlled trial in Japan.

Authors:  Nobuo Anzai; Shusuke Yoneda; Naoki Kumagai; Yukako Nakamura; Emi Ikebuchi; Robert Paul Liberman
Journal:  Psychiatr Serv       Date:  2002-05       Impact factor: 3.084

6.  Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up.

Authors:  G Buchkremer; S Klingberg; R Holle; H Schulze Mönking; W P Hornung
Journal:  Acta Psychiatr Scand       Date:  1997-12       Impact factor: 6.392

7.  Social skills training for schizophrenic individuals at risk for relapse.

Authors:  R P Liberman; K T Mueser; C J Wallace
Journal:  Am J Psychiatry       Date:  1986-04       Impact factor: 18.112

8.  Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia.

Authors:  R P Liberman; C J Wallace; G Blackwell; A Kopelowicz; J V Vaccaro; J Mintz
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

9.  Frequent rehospitalization and noncompliance with treatment.

Authors:  J H Green
Journal:  Hosp Community Psychiatry       Date:  1988-09

10.  [Randomized controlled trial on effectiveness of the community re-entry program to inpatients with schizophrenia spectrum disorder, centering around acquisition of illness self-management knowledge].

Authors:  Kumagai Naoki; Anzai Nobuo; Ikebuchi Emi
Journal:  Seishin Shinkeigaku Zasshi       Date:  2003
View more
  9 in total

1.  Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.

Authors:  Yu-Tao Xiang; Chuan-Yue Wang; Yong-Zhen Weng; Qi-Jing Bo; Helen F K Chiu; Sandra S M Chan; Edwin H M Lee; Gabor S Ungvari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

2.  Cognitive and symptomatic predictors of functional disability in schizophrenia.

Authors:  Syed Shamsi; Adam Lau; Todd Lencz; Katherine E Burdick; Pamela DeRosse; Ron Brenner; Jean-Pierre Lindenmayer; Anil K Malhotra
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

3.  Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Gabor S Ungvari
Journal:  Qual Life Res       Date:  2007-11-23       Impact factor: 4.147

Review 4.  Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.

Authors:  Ori Elis; Janelle M Caponigro; Ann M Kring
Journal:  Clin Psychol Rev       Date:  2013-07-16

Review 5.  Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta-analysis.

Authors:  Yvonne B Suijkerbuijk; Frederieke G Schaafsma; Joost C van Mechelen; Anneli Ojajärvi; Marc Corbière; Johannes R Anema
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

6.  Effectiveness and tolerability of warm-supplementing kidney yang added to risperidone in improving cognitive impairment in patients with schizophrenia: An 8-week, multicenter, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Zhen-Hua Chen; Gao-Hua Wang; Xiao-Ping Wang; Ren-Yun Chen; Hui-Lin Wang; Ming-Hua Yang; Yun-Xiang Huo; Hong-Bing Mei
Journal:  Curr Ther Res Clin Exp       Date:  2008-04

7.  Self-management interventions for people with severe mental illness: systematic review and meta-analysis.

Authors:  Melanie Lean; Miriam Fornells-Ambrojo; Alyssa Milton; Brynmor Lloyd-Evans; Bronwyn Harrison-Stewart; Amina Yesufu-Udechuku; Tim Kendall; Sonia Johnson
Journal:  Br J Psychiatry       Date:  2019-03-22       Impact factor: 9.319

Review 8.  Primary-level worker interventions for the care of people living with mental disorders and distress in low- and middle-income countries.

Authors:  Nadja van Ginneken; Weng Yee Chin; Yen Chian Lim; Amin Ussif; Rakesh Singh; Ujala Shahmalak; Marianna Purgato; Antonio Rojas-García; Eleonora Uphoff; Sarah McMullen; Hakan Safaralilo Foss; Ambika Thapa Pachya; Laleh Rashidian; Anna Borghesani; Nicholas Henschke; Lee-Yee Chong; Simon Lewin
Journal:  Cochrane Database Syst Rev       Date:  2021-08-05

Review 9.  Efficacy of community treatments for schizophrenia and other psychotic disorders: a literature review.

Authors:  Julio Armijo; Emmanuel Méndez; Ricardo Morales; Sara Schilling; Ariel Castro; Rubén Alvarado; Graciela Rojas
Journal:  Front Psychiatry       Date:  2013-10-09       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.